Apr 01, 2020
Online Obsessive-Compulsive Disorder Therapy Provider NOCD Sees Therapy Sessions Double as COVID-19 Brings New Anxieties
Mar 02, 2020
The Florida Council on Compulsive Gambling and Seminole Gaming Urge Consumers to Rebound with the Florida HelpLine during Problem Gambling Awareness Month
Dec 10, 2019
Lottery Tickets as Holiday Gifts for Minors? Know the Risks!
Oct 31, 2019
Promentis Pharmaceuticals Announces Positive Results for Phase 2A Study of SXC-2023 Targeting Novel Glutamatergic Mechanism and Completion of Enrollment for Phase 2 Trichotillomania Study
Oct 11, 2019
Rogers Miami Supports OCD Awareness Week With Community Awareness Event Hosted By OCD Central & South Florida
Apr 12, 2019
10 Questions Is All It Now Takes to Recognize Obsessive-Compulsive Disorder
Mar 01, 2019
The Florida Council on Compulsive Gambling Announces Problem Gambling Awareness Month in Florida
Feb 26, 2019
Delray Center for Healing First in Florida to Treat Patients Suffering From Obsessive-Compulsive Disorder (OCD) with Deep Transcranial Magnetic Stimulation (Deep TMS)
Jan 17, 2019
Promentis Pharmaceuticals Announces Commencement of Phase 2 Studies for SXC-2023 Targeting Novel Glutamatergic Mechanism
Dec 18, 2018
Hope TMS Center Offering Obsessive-Compulsive Disorder (OCD) Treatment with BrainsWay's Deep Transcranial Magnetic Stimulation (Deep TMS)
Dec 05, 2018
Promentis Pharmaceuticals to present at the 57th annual American College of Neuropsychopharmacology (ACNP) meeting
Nov 16, 2018
Promentis Pharmaceuticals Announces Successful Completion of Phase 1 Studies for SXC-2023 Targeting Novel Glutamatergic Mechanism
Aug 09, 2018
HabitAware Receives $300,000 NIH Research Grant to Develop Innovative Awareness Bracelet as a Treatment for Trichotillomania (Hair Pulling Disorder)
Jul 13, 2018
Obsessive Compulsive Disorder Market in Europe 2018: Analysis & Forecasts (2017-2026)
Nov 20, 2017
Promentis Pharmaceuticals Commences Phase 1 Study for SXC-2023 Targeting Neuropsychiatric Disorders